Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
Clinical trial NCT05263206 · RECRUITING
Trial details
- NCT number
- NCT05263206
- Sponsor
- Sanofi
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-15
- Primary completion
- 2027-06-02
- Enrollment
- 284
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.